MC

457.1

-2.14%↓

SANES

10.386

+1.21%↑

SAF

273.2

+0.4%↑

BBVA

18.82

+0.83%↑

BNP

91.41

+1.75%↑

MC

457.1

-2.14%↓

SANES

10.386

+1.21%↑

SAF

273.2

+0.4%↑

BBVA

18.82

+0.83%↑

BNP

91.41

+1.75%↑

MC

457.1

-2.14%↓

SANES

10.386

+1.21%↑

SAF

273.2

+0.4%↑

BBVA

18.82

+0.83%↑

BNP

91.41

+1.75%↑

MC

457.1

-2.14%↓

SANES

10.386

+1.21%↑

SAF

273.2

+0.4%↑

BBVA

18.82

+0.83%↑

BNP

91.41

+1.75%↑

MC

457.1

-2.14%↓

SANES

10.386

+1.21%↑

SAF

273.2

+0.4%↑

BBVA

18.82

+0.83%↑

BNP

91.41

+1.75%↑

Search

Gimv NV

Закрыт

СекторФинансы

47.85 0.21

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

47.5

Макс.

48.3

Ключевые показатели

By Trading Economics

Доход

127M

Продажи

65M

P/E

Средняя по отрасли

8.282

39.62

Прибыль на акцию

3.4

Дивидендная доходность

5.27

Рентабельность продаж

195.239

Сотрудники

94

EBITDA

128M

Дивиденды

By Dow Jones

Дивидендная доходность

Средняя по отрасли

5.27%

4.52%

Следующий отчет о доходах

21 мая 2026 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

1.8B

Предыдущая цена открытия

47.64

Предыдущая цена закрытия

47.85

Новостные настроения

By Acuity

82%

18%

415 / 439 Рейтинг в Finance

Gimv NV График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

27 апр. 2026 г., 23:15 UTC

Главные новостные события

U.K. Consumers Pay Less But Full Impact of Mideast War to Be Seen

27 апр. 2026 г., 23:08 UTC

Отчет
Главные движущие силы рынка

LendingClub Shares Gain on 1Q Profit, Revenue Beat

27 апр. 2026 г., 23:58 UTC

Отчет

Samsung SDI 1Q Net Profit Beat FactSet-Compiled Consensus

27 апр. 2026 г., 23:58 UTC

Отчет

Samsung SDI 1Q Net KRW56.10B Vs. Loss KRW216.00B >006400.SE

27 апр. 2026 г., 23:56 UTC

Отчет

Samsung SDI 1Q Oper Loss KRW155.60B Vs. Loss KRW434.10B >006400.SE

27 апр. 2026 г., 23:56 UTC

Отчет

Samsung SDI 1Q Rev KRW3.576T Vs. KRW3.177T >006400.SE

27 апр. 2026 г., 23:48 UTC

Обсуждения рынка

Nikkei May Remain Rangebound Amid Uncertainty Over Iran Conflict -- Market Talk

27 апр. 2026 г., 23:42 UTC

Обсуждения рынка

Australian Consumer Confidence Making a Slow Come Back -- Market Talk

27 апр. 2026 г., 23:34 UTC

Обсуждения рынка
Главные новостные события

Gold Edges Higher as Investors Assess Iran's Proposal to U.S. -- Market Talk

27 апр. 2026 г., 23:30 UTC

Обсуждения рынка

Australia's NDIS Could Lose 'Social Licence' If Not Reined In -- Market Talk

27 апр. 2026 г., 23:08 UTC

Обсуждения рынка

Polymetals's Revenue Outlook 'Extraordinary' for a Small-Cap Stock -- Market Talk

27 апр. 2026 г., 23:02 UTC

Обсуждения рынка

Global Forex and Fixed Income Roundup: Market Talk

27 апр. 2026 г., 23:02 UTC

Обсуждения рынка

Warsh Will Probably Lean a Bit More Dovish Than Powell -- Market Talk

27 апр. 2026 г., 22:42 UTC

Обсуждения рынка

BOJ Expected to Keep Rates On Hold; Guidance to Skew Hawkish -- Market Talk

27 апр. 2026 г., 22:10 UTC

Отчет

Haier Smart Home: Results Also Weighed by Weak Demand in China-U.S. Markets >600690.SH

27 апр. 2026 г., 22:09 UTC

Отчет

Haier Smart Home: Increase in Tariff Costs, Extreme Weather Conditions Hurt Results >600690.SH

27 апр. 2026 г., 22:09 UTC

Отчет

Haier Smart Home 1Q Net CNY4.65B Vs. Net CNY5.49B >600690.SH

27 апр. 2026 г., 22:09 UTC

Отчет

Haier Smart Home 1Q Rev CNY73.69B Vs. CNY79.12B >600690.SH

27 апр. 2026 г., 21:56 UTC

Отчет

Tsingtao Brewery: Cost Controls Among Factors Supporting Results >0168.HK

27 апр. 2026 г., 21:55 UTC

Отчет

Tsingtao Brewery 1Q Net CNY1.80B Vs. Net CNY1.71B >0168.HK

27 апр. 2026 г., 21:55 UTC

Отчет

Tsingtao Brewery 1Q Rev CNY10.29B Vs. CNY10.45B >0168.HK

27 апр. 2026 г., 21:44 UTC

Отчет

Tianqi Lithium: Higher Demand for Products From EV Sector Also Boosted Financial Performance >002466.SZ

27 апр. 2026 г., 21:43 UTC

Отчет

Tianqi Lithium: Increase in Average Selling Prices of Major Lithium Products Supported Results >002466.SZ

27 апр. 2026 г., 21:41 UTC

Отчет

Tianqi Lithium 1Q Rev CNY5.13B Vs. CNY2.58B >002466.SZ

27 апр. 2026 г., 21:41 UTC

Отчет

Tianqi Lithium 1Q Net CNY1.88B Vs. Net CNY104.27M >002466.SZ

27 апр. 2026 г., 20:50 UTC

Обсуждения рынка

Tech, Media & Telecom Roundup: Market Talk

27 апр. 2026 г., 20:50 UTC

Обсуждения рынка
Главные новостные события

Basic Materials Roundup: Market Talk

27 апр. 2026 г., 20:50 UTC

Обсуждения рынка
Приобретения, слияния, поглощения

Financial Services Roundup: Market Talk

27 апр. 2026 г., 20:50 UTC

Обсуждения рынка

Health Care Roundup: Market Talk

27 апр. 2026 г., 20:39 UTC

Отчет

Nucor: Operating Segments Earnings Growth Driven by Trade Policies That Continue to Reduce Flood of Unfairly Traded Imports Into U.S. >NUE

Сравнение c конкурентами

Изменение цены

Gimv NV Прогноз

Консенсус по рейтингу

By TipRanks

0 ratings

0

Покупка

0

Удержание

0

Продажа

Настроения

By Acuity

415 / 439Рейтинг в Финансы

Новостные настроения

Сильные свидетельства нисходящего тренда

Волатильность

Ниже среднего

Объем новостей (RCV)

Выше среднего

Финансовые показатели

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Gimv NV

Gimv NV is a private equity and venture capital firm specializing in direct and fund of funds investments. For direct investments, the firm specializes in buyouts, growth capital, middle market, debt, shareholder loans, seed, startups, early to mid-stage, late venture, public to private transactions, small and medium sized enterprises, later stage, mature, replacement capital, bridge financing, and recapitalization. Within fund of funds, it seeks to invest in venture capital and private equity funds. It seeks to invest in high performance growth companies that respond to that can speed up their internal growth through acquisitions. The firm typically invests in consumer, connected consumer, fintech; health and care; smart industries; and sustainable cities. Within consumer, it seeks to provide growth capital to emerging leaders. Within health and care platform, the firm seeks to invest in companies that can grow either organically or through a buy and build strategy. Within consumer, it focuses on consumer goods, food and beverage, healthy food, sport, convenience food, personal luxury, career, home & deco, baby & kids, pet products, retail, consumer services, media and content, travel and leisure, education, digital economy and online sectors. Within health and care sector, it focuses on life sciences, medtech, and health and care services. The firm focuses on biotech/biopharma comprising drugs, platform technologies, vaccines and diagnostic tests, preclinical, early clinical, and late clinical, medtech such as medical devices, consumables, IT and small equipment, and health and care services-based companies. It also seeks to be an active shareholder, preferably lead or co-lead in its investments. Within smart industries, it focuses on equipment, services and tools for resource efficient development and production, automotive and aerospace, both optimizing of the existing and development of new means of transport, software and services harnessing the flexibility of the cloud, smart data management and advanced c
help-icon Live chat